Form 8-K - Current report:
SEC Accession No. 0001615219-20-000072
Filing Date
2020-06-19
Accepted
2020-06-19 17:26:52
Documents
3
Period of Report
2020-06-19
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K salarius-form8xkannual.htm 8-K 43236
2 EX-10.1 salarius-2015equityinc.htm EX-10.1 214548
3 EX-10.2 salarius-2015employees.htm EX-10.2 96228
  Complete submission text file 0001615219-20-000072.txt   355253
Mailing Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021
Business Address 2450 HOLCOMBE BLVD SUITE J-608 HOUSTON TX 77021 346-772-0346
Salarius Pharmaceuticals, Inc. (Filer) CIK: 0001615219 (see all company filings)

EIN.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 20976612
SIC: 2834 Pharmaceutical Preparations